Redefining Medicine

A4M
Redefining Medicine

Our podcast Redefining Medicine captures the journeys and stories of healthcare practitioners and innovative visionaries, all of whom are actively changing the way medicine is practiced. Through a more personal and intimate perspective, our interviews will spotlight the most current health technologies, practices, and protocols. As the convergence of medicine and technology strengthens, our podcast will continue to illuminate the most innovative and groundbreaking research--and the clinicians, thought leaders, and researchers behind it.

  1. 11H AGO

    Redefining Medicine with special guests Drs. Sahar Swidan and James LaValle

    James B. LaValle, B.S.Pharm, CCN, MT, DHM, DHPh is an internationally recognized clinical pharmacist, author, and board-certified clinical nutritionist, with over 40 years of clinical experience in natural products, lifestyle, drug/nutrient depletion, compounding pharmacy and peptides. He has served thousands of clients, using a metabolic model for health, at his facilities in Orange County, CA, Austin, TX and formerly at LaValle Metabolic Institute, in Cincinnati Ohio. He is the founder of Metabolic Code Enterprises, (www.metaboliccode.com) that pinpoints the metabolic roadblocks to health using a symptom survey, lab markers, biometrics, and wearable data. He taught for 18 years as an appointed adjunct faculty member at the University of Cincinnati College of Pharmacy served as faculty at the College of Medicine at U.C. He is Adjunct Faculty for the Masters of Integrative Medicine program at the George Washington School of Medicine and Health Sciences. Dr. Swidan is President and CEO of NeuroPharm and Former CEO of Pharmacy Solutions in Ann Arbor, MI and Adjunct Associate Professor of Clinical Research and Leadership at George Washington University School of Medicine and Health Sciences, and Adjunct Clinical Associate Professor of Pharmacy at Wayne State University. She received her Doctor of Pharmacy degree and completed a 3-year research Fellowship in Bio-Pharmaceutics and Gastroenterology at the University of Michigan. Following her fellowship, she was Director of Pharmacy at Chelsea Community Hospital and the clinical pharmacist for the inpatient head and chronic pain service. Dr. Swidan is board certified and an advanced fellow in anti-aging and regenerative medicine. She is an internationally renowned speaker in the areas of pain management, headaches, and HRT. She has authored several book chapters, articles, and patient education material in head and general pain management and personalized medicine.

    13 min
  2. Redefining Medicine with special guest Stephanie Venn Watson, DVM

    MAR 4

    Redefining Medicine with special guest Stephanie Venn Watson, DVM

    Dr. Stephanie Venn-Watson, DVM, MPH is the Co-Founder and CEO of Seraphina Therapeutics, a pioneering health and wellness company dedicated to discovering and developing essential fatty acids that support longevity and overall well-being. A veterinary epidemiologist and the world’s foremost expert on C15:0, the first essential fatty acid discovered in over 90 years, Stephanie has revolutionized the way we think about nutrition and aging.   Her career spans impactful roles, including serving as an epidemiologist for the World Health Organization and U.S. Navy. With over 60 patents and 80 peer-reviewed publications, her innovative approach to nutrient-based therapeutics has been spotlighted by NPR’s Science Friday, CBS, BBC, and National Geographic.   Stephanie’s groundbreaking contributions have earned her prestigious accolades, including the Department of Health and Human Services Secretary’s Award for Innovations in Disease Prevention and Health Promotion and Boehringer Ingelheim’s Innovation Award. Under her leadership, Seraphina Therapeutics has been recognized as a Fast Company World Changing Idea and won Nutritional Outlook Magazine’s Best of the Industry award for its pure C15:0 ingredient.   She holds a B.S. in Animal Physiology and Neuroscience from UC San Diego, a D.V.M. from Tufts University, and an M.P.H. from Emory University. She was also a National Research Council Associate with the Armed Forces Medical Intelligence Center and is an Albert Schweitzer Fellow for Life.

    11 min
  3. FEB 18

    Redefining Medicine with special guests Tom Blue and Sunita Mohanty

    Tom is a Founding Partner of OvationLab, a business advisory and clinical research firm dedicated to assisting businesses and investors in the natural product, testing, digital health, and device spaces to successfully launch and commercialize their products in the healthcare professional channel. Beginning in 2001 with the formation of the first concierge medical practice in Virginia, he has a long history in the design and implementation of novel practice models intended to compress the translational gap between the discovery and the widespread application of best practices in medicine. His most recent new venture in this area is AndHealth, a root cause focused, largely virtual practice funded. Funded in part by the investing arm of the AMA, the company closed the largest seed round ($57M) in the digital health space in 2001.   Sunita Mohanty, Co-founder and CEO of Vibrant, is transforming personalized medicine delivery through AI innovation. Previously, she led AI for AR at Meta and spearheaded groundbreaking products within Meta’s incubator. At Vibrant, she empowers clinicians to practice personalized, preventive medicine while maintaining their independence. Her background includes driving product innovation at Lumosity, founding the kids’ product team, and playing a key role in launching The Primary School, an integrated health and education model. As an angel investor in over 20 companies and a product advisor to startups, she brings deep expertise in scaling healthcare solutions.

    15 min
  4. Redefining Medicine with special guest John Catanzaro, PhD

    12/31/2024

    Redefining Medicine with special guest John Catanzaro, PhD

    Dr. John Catanzaro serves as CEO, Founder, Chairman, and Product Development Officer of Neo7Bioscience, a precision/personalized molecular design biotech company. Dr. Catanzaro received his Doctorate of Naturopathic Medicine (NMD) from Bastyr University in 1995 and his Doctorate of Theology in Science and Medical Ethics (Ph.D. and Th.D.) from Bethany Divinity Seminary in 2012. After 22 years of clinical practice treating patients with cancer and chronic illness, he retired in 2017, where he was the founder and CEO of a cancer institute and research development group of genetic and proteomic technology innovating patient-precision genetically matched immunopeptides. In addition, Dr. Catanzaro is the co-inventor of a precision augmentation platform known as PBIMA. The platform includes multiomic/proteomic sequencing and prediction, CRISPR prime editing features, and proteomics in a 3D integration utilizing unified proprietary mapping informatics and computation, superior ranking, and selection architecture. Dr. Catanzaro is a thought leader in molecular bioscience and biotechnology and brings forth a wealth of knowledge and experience to architect precision-based personalized therapeutics in healthcare. Before his career in medicine and biosciences, he was in various capacities in the aerospace industry, including stints for the USAF and The Boeing Company. Dr. Catanzaro is currently engaged in life science in space and astrobiological research. "My special interest and focus is molecular engineering in space, working with SpacePharma to develop autonomous minisatellite laboratories with diverse orbit and deep space exploration capabilities."

    18 min
    4.6
    out of 5
    44 Ratings

    About

    Our podcast Redefining Medicine captures the journeys and stories of healthcare practitioners and innovative visionaries, all of whom are actively changing the way medicine is practiced. Through a more personal and intimate perspective, our interviews will spotlight the most current health technologies, practices, and protocols. As the convergence of medicine and technology strengthens, our podcast will continue to illuminate the most innovative and groundbreaking research--and the clinicians, thought leaders, and researchers behind it.

    You Might Also Like

    Content Restricted

    This episode can’t be played on the web in your country or region.

    To listen to explicit episodes, sign in.

    Stay up to date with this show

    Sign in or sign up to follow shows, save episodes, and get the latest updates.

    Select a country or region

    Africa, Middle East, and India

    Asia Pacific

    Europe

    Latin America and the Caribbean

    The United States and Canada